OrbiMed Advisors acquires 1,333,333 Electra Therapeutics shares for USD 20 million
Bitget2026/09/23 21:30- OrbiMed Advisors, a director and 10% owner, reported a sharp increase in its indirect stake in Electra Therapeutics.
- Indirect holdings rose to 5,126,891 common shares, including 1,333,333 shares bought at USD 15 in the IPO.
- A separate OrbiMed-related position increased to 1,758,279 common shares, including 1,000,000 shares bought at USD 15.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
